The Korean Journal of Gastroenterology (대한소화기학회지)

The Korean Society of Gastroenterology (대한소화기학회)
권호 표지

Current Researches on the Virulence Factors of Helicobacter pylori

Helicobacter pylori 병독인자의 연구 현황

Kim, Jung-Mogg
김정목

  • Published : 20030200
⟨ Previous Next ⟩

Abstract

Helicobacter pylori (H. pylori), a gram-negative spiral-shaped bacterium, specifically colonizes the human stomach. Once established in this harsh ecological niche, it stays there virtually for the entire life of the host. To date, numerous virulence factors responsible for gastric colonization, survival, and tissue damage have been described for this bacterium. It is now well established that urease and flagella are virulence factors of H. pylori. Vacuolating cytotoxin (VacA), cytotoxin-associated gene A (CagA), and cag pathogenicity island have also emerged as virulence factors, although the specific genes involved in virulence are still being determined. OipA (outer inflammatory proteins), H. pylori neutrophil-activating protein (HP-NAP), and several adhesins, including BabA (blood group A antigen-binding adhesin) and IceA (induced by contact with epithelium), have been reported to be important virulence factors of H. pylori. In addition, CagE (picB) and lipopolysaccharide are considered as other possible virulence factors. Since many researchers have defined virulence factors as those that contribute to inflammation and gastroduodenal diseases by H. pylori infection, it would be possible to define the role of specific factors in virulence and to develop novel therapeutic drugs or vaccines to treat and prevent H. pylori infection more easily.

Keywords

References

  1. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37 https://doi.org/10.1038/nrc703
  2. Ge Z, Taylor DE. Contributions of genome sequencing to understanding the biology of Helicobacter pylori. Annu Rev Microbiol 1999;53:353-387 https://doi.org/10.1146/annurev.micro.53.1.353
  3. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 2001;19:523-563 https://doi.org/10.1146/annurev.immunol.19.1.523
  4. Kim YB, Hahm KB, Lee KM Han SU, Kim MW. Animal models of Helicobacter pylori infections. Korean J Gastroenterol 2001;37:399-405
  5. Yoshiyama H, Nakazawa T. Unique mechanism of Helicobacter pylori for colonizing the gastric mucus. Microbes Infect 2000;2:55-60 https://doi.org/10.1016/S1286-4579(00)00285-9
  6. Jung HC, Kim JM, Song IS, Kim CY. Increased motility of Helicobacter pylori by methylcellulose could upregulate the expression of proinflammatory cytokines in human gastric epithelial cells. Scand J Clin Lab Invest 1997;57:263-270 https://doi.org/10.3109/00365519709060035
  7. Ottemann KM, Lowenthal AC. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 2002;70:1984-1990 https://doi.org/10.1128/IAI.70.4.1984-1990.2002
  8. Montecucco C, Rappuoli R. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Bioi 2001;2:457-466 https://doi.org/10.1038/35073084
  9. van Vliet AH, Kuipers EJ, Waidner B, et al. Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect Immun 2001;69:4891-4897 https://doi.org/10.1128/IAI.69.8.4891-4897.2001
  10. Mobley HL, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995;59:451-480
  11. Tsuda M, Karita M, Morshed MG, Okita K, Nakazawa T. A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect Immun 1994;62:3586-3589
  12. Desai MA, Vadgarna PM. An in vitro study of enhanced H+ diffusion by urease action on urea. Implications for Helicobacter pylori-associated peptic ulceration. Scand J Gastroenterol 1993;28:915-919 https://doi.org/10.3109/00365529309103135
  13. Figura N. Identifiable Helicobacter pylori strains or factors important in the development of duodenal ulcer disease. Helicobacter 1997;2(Suppl 1):S3-S12 https://doi.org/10.1111/j.1523-5378.1997.06b06.x
  14. McGee OJ, Mobley HL. Mechanisms of Helicobacter pylori infection: bacterial factors. Curro Top. Microbiol. Immunol. 1999;241:155-180
  15. Appelmelk BJ, Monteiro MA, Martin SL, Moran AP, Vandenbroucke-Grauls CM. Why Helicobacter pylori has Lewis antigens. Trends Microbiol 2000;8:565-570 https://doi.org/10.1016/S0966-842X(00)01875-8
  16. Rad R, Gerhard M, Lang R, et al. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 2002;168:3033-3041 https://doi.org/10.4049/jimmunol.168.6.3033
  17. Mizushima T, Sugiyama T, Komatsu Y, Ishizuka I, Kato M, Asaka M. Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol 2001;39: 2463-2465 https://doi.org/10.1128/JCM.39.7.2463-2465.2001
  18. Kim SY, Woo CW, Lee YM, et al. Genotyping cagA, vacA subtype, iceA1, and babA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseases. J Korean Med Sci 2001;16:579-584 https://doi.org/10.3346/jkms.2001.16.5.579
  19. Mahdavi I, Sonden B, Hurtig M, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002;297:573-578 https://doi.org/10.1126/science.1069076
  20. Peek RM Jr, Thompson SA, Donahue JP, et al. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians 1998;110:531-544
  21. Figueiredo C, Quint WG, Sanna R, et al. Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori. Gene 2000;246:59-68 https://doi.org/10.1016/S0378-1119(00)00054-8
  22. Nishiya D, Shimoyarna T, Fukuda S, et al. Evaluation of the clinical relevance of the iceAl gene in patients with Helicobacter pylori infection in Japan. Scand J Gastroenterol 2000;35:36-39 https://doi.org/10.1080/003655200750024506
  23. van Doom U, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA and iceA status of Helicobacter pylori. Gastroenterology 1998;115:58-66 https://doi.org/10.1016/S0016-5085(98)70365-8
  24. Lee JW, Jeong S, Kim IH, et al. Relationship between gene subtype of Helicobacter pylori virulence factor and upper gastrointestinal diseases. Korean J Gastroenterol 2001;38:89-97
  25. Lundstrom AM, Blom K, Sundaeus V, Bolin I. HpaA shows variable surface localization but the gene expression is similar in different Helicobacter pylori strains. Microb Pathog 2001;31:243-253 https://doi.org/10.1006/mpat.2001.0466
  26. Peck B, Ortkamp M, DieW KD, Hundt E, Knapp B. Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucleic Acids Res 1999;27:3325-3333 https://doi.org/10.1093/nar/27.16.3325
  27. Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type l-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996;93:14648-14653 https://doi.org/10.1073/pnas.93.25.14648
  28. Kim JM, Kim JS, lung HC, Song IS, Kim CY. Virulence factors of Helicobacter pylori in Korean strains do not influence proinflammatory cytokine gene expression and apoptosis in human gastric epithelial cells, nor do these factors influence clinical outcome. J Gastroenterol 2000;35:898-906 https://doi.org/10.1007/s005350070003
  29. Kim JM, lung HC, Lee JY, et al. Prevalence of virulence factors in Helicobacter pylori isolated from Koreans and proinflammatory cytokine gene expression in human gastric epithelial cells induced by H. pylori with virulence factors. Korean J Med 1998;54:40-51
  30. Kim DY. The positive rates of Helicobacter pylori cagA gene in gastric biopsy specimens of the patients with gastritis, gastric ulcer, duodenal ulcer, and gastric cancer and comparison of the degree of gastritis. Korean J Gastroenterol. 1998;32:24-31
  31. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16(Suppl 1):3-15
  32. Perez-Perez GI, Peek RM, Legath AJ, Heine PR, Graff LB. The role of CagA status in gastric and extragastric complications of Helicobacter pylori. J Physiol Pharmacol 1999;50:833-845
  33. Park SM, Park J, Kim JG, et al. Infection with Helicobacter pylori expressing the cagA gene is not associated with an increased risk of developing peptic ulcer diseases in Korean patients. Scand J Gastroenterol 1998;33:923-927 https://doi.org/10.1080/003655298750026921
  34. Backert S, Maese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 2001;42:631-644 https://doi.org/10.1046/j.1365-2958.2001.02649.x
  35. Nawnann M. Host cell signaling in Helicobacter pylori infection. Int J Med Microbiol 2001;291:299-305 https://doi.org/10.1078/1438-4221-00133
  36. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 2002;43:971-980 https://doi.org/10.1046/j.1365-2958.2002.02781.x
  37. Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002;295:683-686 https://doi.org/10.1126/science.1067147
  38. Covacci A, Rappuoli R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med 2000;191:587-592 https://doi.org/10.1084/jem.191.4.587
  39. Censini S, Stein M, Covacci A. Cellular responses induced after contact with Helicobacter pylori. Curr Opin Microbiol 2001;4:41-46 https://doi.org/10.1016/S1369-5274(00)00162-4
  40. Selbach M, Maese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Bioi Chem 2002;277:6775-6778 https://doi.org/10.1074/jbc.C100754200
  41. Puis J, Fischer W, Haas R. Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Mol Microbiol 2002;43:961-969 https://doi.org/10.1046/j.1365-2958.2002.02780.x
  42. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999;96:14559-14564 https://doi.org/10.1073/pnas.96.25.14559
  43. Ferbe D. Carcinogenic bacteria. Cracking gut bugs' cellskewing strategy. Science 2001;294:2269
  44. Tummuru MK, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995;18:867-876 https://doi.org/10.1111/j.1365-2958.1995.18050867.x
  45. Ogura K, Maeda S, Nakao M, et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med 2000;192:1601-1610 https://doi.org/10.1084/jem.192.11.1601
  46. Munzenmaier A, Lange C, Glocker E, et al. A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol 1997;159:6140-6147
  47. Papini E, Zoratti M, Cover TL. In search of the Helicobacter pylori VacA mechanism of action. Toxicon 2001;39:1757-1767 https://doi.org/10.1016/S0041-0101(01)00162-3
  48. Reyrat JM, Pelicic V, Papini E, Montecucco C, Rappuoli R, Telford JL. Towards deciphering the Helicobacter pylori cytotoxin. Mol Microbiol 1999;34:197-204 https://doi.org/10.1046/j.1365-2958.1999.01592.x
  49. Xiang Z, Censini S, Bayeli PF, et al. Analysis and expression of cagA and vacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-98
  50. Kim JM, Kim JS, Jung HC, Song IS, Kim CY. Apoptosis of human gastric epithelial cells via caspase-3 activation in response to Helicobacter pylori infection: Possible involvement of neutrophils through tumor necrosis factor-alpha and soluble Fas ligands. Scand J Gastroenterol 2000;35:40-48 https://doi.org/10.1080/003655200750024515
  51. Kim JM, Kim JS, Jung HC, Song IS, Kim CY. Upregulated cyclooxygenase-2 inhibits apoptosis of human gastric epithelial cells infected with Helicobacter pylori. Dig Dis Sci 2000;45:2436-2443 https://doi.org/10.1023/A:1005611613542
  52. Kim JM, Kim JS, Jung HC, Song IS, Kim CY. Up-regulation of inducible nitric oxide synthase and nitric oxide in Helicobacter pylori-infected human gastric epithelial cells: possible role of interferon- $\gamma$ in polarizednitric oxide secretion. Helicobacter 2002;7:116-128 https://doi.org/10.1046/j.1083-4389.2002.00068.x
  53. van Doorn LJ, Figueiredo C, Megraud F, et al. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 1999;116:823-830 https://doi.org/10.1016/S0016-5085(99)70065-X
  54. Atherton JC, Sharp PM, Cover TL, et al, Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination. Curr Microbiol 1999;39:211-218
  55. Kim SK. Relationship between Helicobacter pylori virulence factors and clinical outcomes. Korean J Helicobacter Res Pract 2002;2:219-223
  56. Galmiche A, Rassow J, Doye A, et al, The N-tenninal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 2000;19:6361-6370
  57. Supajatura V, Ushio H, Wada A, et al. Cutting edge; VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002;168:2603-2607 https://doi.org/10.4049/jimmunol.168.6.2603
  58. Molinari M, Salio M, Galli C, et al. Selective inhibition of li-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 1998;187:135-140 https://doi.org/10.1084/jem.187.1.135
  59. Tombola F, Morbiato L, Del Giudice G, Rappuoli R, Zoratti M, Papini E. The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J Clin Invest 2001;108:929-937 https://doi.org/10.1172/JCI13045
  60. Salama NR, Otto G, Tompkins L, Falkow S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun 2001;69:730-736 https://doi.org/10.1128/IAI.69.2.730-736.2001
  61. Evans DJ Jr, Evans DG, Takemura T, et al. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun 1995;63:2213-2220
  62. Dundon WG, de Bernard M, Montecucco C. Virulence factors of Helicobacter pylori. Int J Med Microbiol 2001;290:647-658 https://doi.org/10.1016/S1438-4221(01)80002-3
  63. Dundon WG, Nishioka H, Polenghi A, et al. The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol 2002;291:545-550 https://doi.org/10.1078/1438-4221-00165
  64. Satin B, Del Giudice G, Della Bianca V, et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 2000;191:1467-1476 https://doi.org/10.1084/jem.191.9.1467
  65. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proin-flammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 2000;97:7533-7538 https://doi.org/10.1073/pnas.130079797
  66. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002;123:414-424 https://doi.org/10.1053/gast.2002.34781
  67. Yamaoka Y, Kita M, Kodama T, et al. Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology 2002;123:1992-2004 https://doi.org/10.1053/gast.2002.37074
  68. Rasko DA, Keelan M, Wilson TJ, Taylor DE. Lewis antigen expression by Helicobacter pylori. J Infect Dis 2001;184:315-321 https://doi.org/10.1086/322025
  69. Lieber CS. Gastric ethanol metabolism and gastritis: interactions with other drugs, Helicobacter pylori, and antibiotic therapy (1957-1997)-a review. Alcohol Clin Exp Res 1997;21:1360-1366
  70. Roine RP, Salmela KS, Salaspuro M. Alcohol metabolism in Helicobacter pylori-infected stomach. Ann Med 1995;27:583-588 https://doi.org/10.3109/07853899509002473
  71. Megraud F. Toxic factors of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6(Suppl 1):S5-10
  72. Yamaguchi H, Osaki T, Kai M, Taguchi H, Karniya S. Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori. Infect Immun 2000;68:3448-3454 https://doi.org/10.1128/IAI.68.6.3448-3454.2000
  73. Smoot DT. How does Helicobacter pylori cause mucosal damage? Direct mechanisms. Gastroenterology 1997;113(suppl 6): S31-34 https://doi.org/10.1016/S0016-5085(97)80008-X
  74. Seyler RW Jr, Olson JW, Maier RJ. Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization. Infect Immun 2001;69:4034-4040 https://doi.org/10.1128/IAI.69.6.4034-4040.2001
  75. Ando T, Wassenaar TM, Peek RM Jr, et al. A Helicobacter pylori restriction endonuclease-replacing gene, hrgA, is associated with gastric cancer in Asian strains. Cancer Res 2002;62:2385-2389